We constructed a dominant negative form of human hypoxia-inducible factor (HIF)-2, HIF-2DoN, which inhibited HIF transcriptional activity induced by hypoxia and by HIF-2. HIF-2DoN formed a complex with HIF-1 and interacted with DNA containing hypoxia response elements (HREs). Thus, the complex appears to inhibit the binding of HIF-2 to HREs, and HIF-2DoN might provide a useful therapeutic tool for HIF-2-related diseases.
Mammalian cells upregulate the expression of genes related to energy metabolism, vascularization, and erythropoiesis in response to hypoxia. 1) Upregulation of the expression of such genes largely depends on the expression of hypoxia-inducible factor (HIF).
2) HIF binds to consensus hypoxia response elements (HREs) in hypoxia-responsive genes, followed by activation of the transcription of their genes. HIF is composed of and subunits. The -subunit is stably expressed when oxygen concentrations are reduced. The -subunit (HIF-1), which is required for DNA binding and the consequent transcriptional response, is constitutively expressed. Two types of -subunit isoforms, HIF-1 and HIF-2, share a common modular structure that is composed of a basic helix-loop-helix (bHLH)-containing PER-ARNT-SIM (PAS) (bHLH/PAS) domain, an oxygen-dependent degradation (ODD) domain, an N-terminal transactivation domain (N-TAD), and a C-terminal transactivation domain (C-TAD). 3, 4) Two nuclear localization signals are located in the N-and C-terminal regions. The bHLH region and the PAS domain are required for DNA binding and dimerization with HIF-1 respectively. The ODD domain includes two critical proline residues, which are hydroxylated under normoxia. Hydroxylated HIF-undergoes ubiquitination and subsequent proteasome-dependent degradation, 5) but HIF-1 and HIF-2 are expressed in distinct temporal and spatial patterns, and do not function redundantly. [6] [7] [8] Thus the expression of hypoxia-responsive genes depends mainly on the amount and isoform of the -subunit that is expressed in response to hypoxia. Solid tumors have unique hypoxic microenvironments, and tumor growth in hypoxia is largely regulated by HIF-mediated gene expression. Therefore, inhibitors of HIF transcriptional activity might be useful as therapeutic tools for hypoxia-related diseases such as cancers. 9) Recently, alternatively spliced isoforms of HIF-1 have been reported. 5) Two of six HIF-1 isoforms, including wild-type HIF-1, function as dominant negative isoforms of HIF-1. On the other hand, no alternatively spliced variants of HIF-2 have been found. HIF-1 and HIF-2 differ in target gene specificity and tumorigenic activity. If dominant negative isoforms of HIF-2 bind to HREs in HIF-2-responsive genes, such isoforms are expected to be useful as therapeutic tools for HIF-2-related diseases, including cancers. In the present study, we constructed a dominant negative form of human HIF-2 and determined its function.
Total RNA was extracted from human hepatoma HepG2 cells, and was reverse-transcribed to synthesize cDNAs. Because the human HIF-2 gene is composed of 16 exons, the presence of splicing variants of HIF-2 was monitored by reverse transcription (RT)-PCR analysis between exons 1 and 9 and between exons 9 and 16. The two RT-PCR products covered the fulllength open reading frame of HIF-2 mRNA. As shown in Fig. 1A , the RT-PCR products between exons 1 and 9 were detected as a single band by Southern blot analysis, cloned, and sequenced. The nucleotide sequence analysis of cloned DNA was identical to that of the authentic form of HIF-2 mRNA, indicating that there were no splicing variants between exons 1 and 9 of HIF-2 mRNA. On the other hand, Southern blot analysis of the RT-PCR products between exons 9 and 16 detected seven bands. The RT-PCR products corresponding to five of the bands were cloned and sequenced. The biggest PCR fragment corresponded to the authentic form of HIF-2 mRNA, and the second-smallest PCR fragment, which was faintly detected, was identified as a variant lacking exons 12 to 15 of HIF-2 mRNA. In the y To whom correspondence should be addressed. Fax: +81-72-254-9921; E-mail: yamaji@biochem.osakafu-u.ac.jp Abbreviations: bHLH, basic helix-loop-helix; C-TAD, C-terminal transactivation domain; HA, hemagglutinin; HIF, hypoxia-inducible factor; HRE, hypoxia response element; N-TAD, N-terminal transactivation domain; ODD, oxygen-dependent degradation; PAS, PER-ARNT-SIM; RT-PCR, reverse transcription-PCR present study, we could not clone the cDNA encoding an alternatively spliced isoform lacking exons 12 to 15 of HIF-2 mRNA (termed HIF-2DoN). However, as shown in Fig. 1B , the deduced structure of HIF-2DoN allowed us to predict that HIF-2DoN functions as a dominant negative form of HIF-2. Thus, in HIF2DoN, the joining of exons 11 and 16 resulted in the generation of a new reading frame for exon 16 (the shaded box in Fig. 1B) . Hence the deduced amino acid sequence of HIF-2DoN was composed of 518 amino acids encoded by exons 1 to 11 and an additional 18 amino acids encoded by exon 16. HIF-2DoN conserved the bHLH/PAS, the N-terminal nuclear localization signal, and the N-terminal part of N-TAD in the ODD domain. These structural features suggest that HIF2DoN can bind to DNA, interact with HIF-1, and translocate to the nucleus, but cannot induce HIF transcriptional activity.
To determine whether HIF-2DoN inhibits endogenous HIF transcriptional activity, a cDNA encoding HIF-2DoN was constructed. HEK293 cells were transfected with pH2DoN and pHRE-Luc, followed by exposure to hypoxia. pH2DoN is an expression vector encoding N-terminal HA-and C-terminal Myc-tagged HIF-2DoN, and pHRE-Luc is a reporter vector that has three tandem repeats of an HRE of the human erythropoietin 3 0 -flanking region in pGL3-promoter vector. 10) HRE of erythropoietin has a higher affinity for HIF-2 than HIF-1.
11) HIF-2DoN suppressed hypoxia-induced HIF transcriptional activity in a dosedependent manner (Fig. 2A) . In contrast, HIF-2DoN had no HIF transcriptional activity, although HIF2DoN has the N-terminal part of N-TAD, which plays a dominant role in transactivation of hypoxia-responsive genes. 12) To determine the inhibitory effect of HIF-2DoN on HIF-1-or HIF-2-induced HIF transcriptional activity, HIF-1DM and HIF-2DM cDNAs encoding mutant HIF-1 and HIF-2, which are stably expressed even in normoxia, were synthesized by site-directed mutagenesis. 13 1 mg) , and pH2DoN (0.1 or 0.5 mg) for 24 h, followed by incubation in fresh medium for 12 h. Cells were cultured for an additional 9 h in hypoxia (1% O 2 ), and luciferase activity was determined. The samples of luciferase reporter assay were separated by SDS-PAGE and subjected to Western blot analysis with anti-c-Myc antibody. B, HEK293 cells were transiently transfected with pRL-SV40 (0.005 mg), pHRE-Luc (0.1 mg), pH2DoN (0.1 or 0.5 mg), and either pH1DM or pH2DM (0.1 mg) for 24 h, followed by incubation in fresh medium for 24 h, and luciferase activity was determined. Reporter assays were performed in triplicate. Values are shown as mean AE SD. Results are representative of three independent experiments. activity in a dose-dependent manner when co-expressed (Fig. 2B) . HIF-2DoN was effective at inhibiting HIF-2 activity at a lower dose. These results indicate that HIF2DoN functions as a dominant negative form, which competes with the -subunits of HIF, especially HIF-2.
We examined to determine whether HIF-2DoN interacts with HIF-1. N-terminal three tandem FLAGtagged HIF-2DoN or HIF-2DM expression vector (pFLAG-H2DoN or pFLAG-H2DM) was transiently transfected into HEK293 cells, and immunoprecipitation analysis with anti-HIF-1 IgG was performed. Anti-HIF-1 IgG co-immunoprecipitated HIF-2DoN or HIF-2DM with HIF-1, whereas control IgG immunoprecipitated neither HIF-1, HIF-2DoN, nor HIF-2DM (Fig. 3A) .
Next, to assess whether HIF-2DoN binds to HREs, an expression vector, pH2DoN or pH2DM, was co-transfected with pHRE-Luc, and plasmid immunoprecipitation analysis with anti-HA antibody was performed. 14) As shown in Fig. 3B , HIF-2DoN interacted with DNA containing HREs in pHRE-Luc. These results suggest that a complex composed of HIF-2DoN and HIF-1 inhibits the binding of authentic HIFs, especially HIF-2, to HREs. In contrast, two HIF-1 dominant negative isoforms, HIF-1Z 15) and HIF-1 516 , 16) interact with HIF-1 in the cytosol and appear to block the nuclear translocation of HIF-1. Thus the mechanisms by which HIF-2DoN and HIF-1 variants inhibit HIF transcriptional activity might be different.
Inhibition of HIF-function has been proposed as a novel strategy to suppress tumor growth 17) because HIF-1 and HIF-2 are expressed in tumor cells and regulate the expression of genes involved in tumor cell survival. 18) In the present study, although we did not prove the presence of endogenous HIF-2DoN, HIF2DoN is expected to be useful as a therapeutic tool for cancers (e.g., breast cancer and renal cancer) that preferentially express HIF-2. A, HEK293 cells were transiently transfected with pFLAG-H2DM or pFLAG-H2DoN (5 mg) for 6 h, followed by incubation in fresh medium for 42 h. Cell lysates were prepared and incubated with 1 mg of anti-HIF-1 IgG or control mouse IgG, followed by the addition of protein G-Sepharose. Immunoprecipitated proteins were separated by SDS-PAGE and subjected to Western blot analyses with anti-FLAG and anti-HIF-1 antibodies. Each graph is representative of two independent experiments. B, HEK293 cells were transiently transfected with pHRE-Luc (2 mg) and pH2DM or pH2DoN (1 mg) for 6 h, followed by incubation in fresh medium for 42 h. Soluble DNA was prepared and incubated with anti-HA IgG or control rat IgG, followed by incubation with protein G-Sepharose. Immunoprecipitated DNAs were extracted with phenol-chloroform and precipitated with ethanol. The DNA, containing three HREs of pHRE-Luc, was amplified by PCR using a sense primer (5 0 -CTAGCAAAATAGGCTGTCCC-3 0 ) and an antisense primer (5 0 -CTTTATGTTTTTGGCGTCTTCC-3 0 ).
